Project Grant R01AT013248
- The National Institute of Neurological Disorders and Stroke (NINDS) awarded Mayo Clinic Jacksonville $2,277,111 on September 15, 2026, under the Drug Use and Addiction Research Programs (CFDA 93.279) to develop the PAIN (Pain AI Intervention) platform, a wearable sensor-based artificial intelligence system for at-home continuous pain monitoring and personalized opioid management. The project addresses limitations in patient-reported pain scales by deploying validated deep learning algorithms...
- The National Center for Complementary and Integrative Health (part of the Department of Health and Human Services National Institutes of Health) awarded $164,268 to the University of Washington on April 15, 2026, under the Research and Training in Complementary and Integrative Health program (CFDA 93.213) to optimize mindfulness-based cognitive therapy practice for chronic pain in people with multiple sclerosis. The award funds a K23 career development project running through March 31, 2031,...
- The Department of Health and Human Services National Institutes of Health Office of the Director awarded Beth Israel Deaconess Medical Center, Inc. (BIDMC) $637,845 on June 19, 2026, under the Research and Training in Complementary and Integrative Health program (CFDA 93.213). The award funds a remote, randomized controlled study assessing the efficacy of mindfulness apps for people with depression using precision medicine methodology. The research compares participants randomized to...
- The National Center for Complementary and Integrative Health, within the Department of Health and Human Services National Institutes of Health, awarded Yale University $634,664 on August 28, 2026, under the Research and Training in Complementary and Integrative Health program (CFDA 93.213) to conduct a multi-site feasibility trial of smartphone-based mindfulness treatment for promoting addiction recovery. The award funds development and testing of a digital mindfulness-based treatment designed...
- The National Institutes of Health National Center for Complementary and Integrative Health awarded New York University $785,637 under the Research and Training in Complementary and Integrative Health program (CFDA 93.213) from June 2021 through May 2025. This Cooperative Agreement will support the development and pilot testing of telephone-delivered and video-based Mindfulness-Based Cognitive Therapy (MBCT) protocols for patients with migraine headaches and depressive symptoms. Specifically, the...
- The National Center for Complementary and Integrative Health, part of the Department of Health and Human Services National Institutes of Health, awarded Duke University $444,125 on August 13, 2026, under the Research and Training in Complementary and Integrative Health program (CFDA 93.213) to test the feasibility and acceptability of a psychological support and resource navigator program for orthopedic patients with high-impact chronic musculoskeletal pain. The navigator program addresses the...
- The National Center for Complementary and Integrative Health (NCCIH) at the National Institutes of Health awarded The General Hospital Corporation, doing business as Massachusetts General Hospital, $170,640 on April 17, 2026, under the Research and Training in Complementary and Integrative Health program (CFDA 93.213). The award funds development and feasibility testing of TOPMED (Toolkit for Optimal Pain Management in the Emergency Department), a mind-body intervention designed to reduce pain...
- The National Center for Complementary and Integrative Health of the Department of Health and Human Services awarded Southern California University of Health Sciences $535,524 on August 15, 2026, under the Research and Training in Complementary and Integrative Health program (CFDA 93.213) to assess the quality and value of non-pharmacological therapies compared to prescription drug therapy for managing spinal pain in Medicare beneficiaries aged 65 and older. The research will use Medicare...
- The National Center for Complementary and Integrative Health, part of the Department of Health and Human Services National Institutes of Health, awarded $398,970 to the University of Alabama at Birmingham on August 15, 2026, under the Research and Training in Complementary and Integrative Health program (CFDA 93.213). The award funds development of soft wearable electronic skin sensors to quantify real-time complex force dynamics during force-based manipulation and manual therapy. The soft...
- The National Institute of Neurological Disorders and Stroke awarded Mayo Clinic $622,784 on July 21, 2026, under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853) to investigate acute and chronic repercussions of spinal cord stimulation following spinal cord injury. The research quantifies blood pressure instability after spinal cord injury, which interrupts descending autonomic regulatory signals and causes loss of consciousness, stroke,...
The National Institutes of Health National Center for Complementary and Integrative Health awarded Mayo Clinic Jacksonville $780,208 on September 1, 2026, under the Research and Training in Complementary and Integrative Health program (CFDA 93.213) to conduct a randomized controlled trial evaluating the efficacy of a mobile app-based mindfulness intervention for managing chronic pain in persons with spinal cord injury. The study addresses a clinical gap: chronic pain affects 65–85% of people with spinal cord injury, contributes to depression and anxiety, and limits participation in activities of daily living, yet standard pharmacological agents such as opioids are ineffective and carry significant side effects. Mindfulness meditation training has demonstrated benefit for chronic pain in non-spinal-cord-injury populations, but traditional in-person interventions are lengthy, expensive, and inaccessible to many patients. The recipient's prior NIH-funded feasibility study showed that a free, publicly available mobile app-based mindfulness intervention was feasible and acceptable in this population and showed promise in improving pain and mental health outcomes. This project grant will conduct a full-powered efficacy trial to establish whether the app-based intervention meaningfully improves pain and quality of life compared to standard care, with the ultimate goal of identifying and disseminating accessible tools for a population facing barriers to conventional healthcare services. Performance occurs in Jacksonville, Florida, with a period of performance through August 31, 2031.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $780.2k | 9/1/26 |